ReVia
PubChem Notes:
Naltrexone Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence.
Molecular Formula:
C20H24ClNO4
InChI: InChI=1/C20H23NO4.ClH/c22-13-4-3-12-9-15-20(24)6-5-14(23)18-19(20,16(12)17(13)25-18)7-8-21(15)10-11-1-2-11;/h3-4,11,15,18,22,24H,1-2,5-10H2;1H/t15-,18+,19+,20-;/m1./s1
InChIKey: InChIKey=RHBRMCOKKKZVRY-ITLPAZOVBS
SMILES: C1CC1CN2CCC34C5C(=O)CCC3(C2CC6=C4C(=C(C=C6)O)O5)O.Cl
Names:
D02095
Naltrexone hydrochloride (USP)
Naltrexone hydrochloride
ReVia (TN)
ReVia
16676-29-2
Registries:
PubChem CID 5485201
PubChem ID 7849156
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|